SEC Form 4 · accession 0001493152-26-034516
CytoMed Therapeutics Ltd · GDTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chee Kong Choo
Director · 10% Owner
Period of report
Jul 14, 2026
Accepted (ET)
Jul 24, 2026 · 12:33 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001873093
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED | Jul 14, 2026 | P | 100,000 | $1.50 | D | 530,324 | D | |
| ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED | Jul 20, 2026 | P | 100,000 | $1.50 | D | 630,324 | D |
Table II — derivative securities
No Table II lines on this filing.